NO20041485L - Farmasoytisk formulering omfattende (R)-bicalutamid - Google Patents

Farmasoytisk formulering omfattende (R)-bicalutamid

Info

Publication number: NO20041485L
Authority: NO; Norway
Prior art keywords: bicalutamide; pharmaceutical formulation; formulation; pharmaceutical
Prior art date: 2001-10-15

Application number

NO20041485A

Other languages

English (en)

Inventor

Nicola Frances Bateman

Original Assignee

Astrazeneca Uk Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-15

Filing date

2004-04-13

Publication date

2004-04-13

2004-04-13 Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd

2004-04-13 Publication of NO20041485L publication Critical patent/NO20041485L/no

Links

LKJPYSCBVHEWIU-KRWDZBQOSA-N (R)-bicalutamide Chemical compound C([C@@](O)(C)C(=O)NC=1C=C(C(C#N)=CC=1)C(F)(F)F)S(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-KRWDZBQOSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20041485A 2001-10-15 2004-04-13 Farmasoytisk formulering omfattende (R)-bicalutamid NO20041485L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0103424A SE0103424D0 (sv)	2001-10-15	2001-10-15	Pharmaceutical formulation
PCT/GB2002/004621 WO2003032950A1 (en)	2001-10-15	2002-10-11	Pharmaceutical formulation comprising (r) -bicalutamide

Publications (1)

Publication Number	Publication Date
NO20041485L true NO20041485L (no)	2004-04-13

Family

ID=20285650

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20041485A NO20041485L (no)	2001-10-15	2004-04-13	Farmasoytisk formulering omfattende (R)-bicalutamid

Country Status (19)

Country	Link
US (1)	US20060058381A1 (no)
EP (1)	EP1439823A1 (no)
JP (1)	JP3639587B2 (no)
KR (1)	KR20050035163A (no)
CN (1)	CN1571658A (no)
AR (1)	AR036877A1 (no)
BR (1)	BR0213248A (no)
CA (1)	CA2462219A1 (no)
CO (1)	CO5580755A2 (no)
HU (1)	HUP0401369A3 (no)
IL (1)	IL161306A0 (no)
IS (1)	IS7219A (no)
MX (1)	MXPA04003520A (no)
NO (1)	NO20041485L (no)
PL (1)	PL368226A1 (no)
RU (1)	RU2004115023A (no)
SE (1)	SE0103424D0 (no)
WO (1)	WO2003032950A1 (no)
ZA (1)	ZA200402729B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ20032225A3 (cs) *	2001-02-27	2003-11-12	Astrazeneca Ab	Farmaceutická formulace
JP5122144B2 (ja)	2004-01-20	2013-01-16	ノバルティスアーゲー	直接圧縮製剤および方法
WO2006090129A2 (en) *	2005-02-23	2006-08-31	Astrazeneca Ab	Bicalutamide for delivering increasing steady state plasma levels
US20080045600A1 (en) *	2006-08-17	2008-02-21	Gawande Rahul S	Bicalutamide compositions
US20100048524A1 (en)	2008-03-14	2010-02-25	Angela Brodie	Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
EP2393827B1 (en)	2009-02-05	2015-10-07	Tokai Pharmaceuticals, Inc.	Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
CN101987086B (zh) *	2009-08-03	2012-07-18	北京化工大学	一种超细比卡鲁胺口服片剂及其制备方法
JP2014523445A (ja) *	2011-07-18	2014-09-11	トーカイファーマシューティカルズ，インク．	前立腺癌を処置するための新規な組成物及び方法
TWI673051B (zh)	2012-09-11	2019-10-01	美商梅維森前列腺療法有限責任公司	恩雜魯它脈（ｅｎｚａｌｕｔａｍｉｄｅ）之調和物
CA2904170A1 (en)	2013-03-14	2014-09-25	University Of Maryland, Baltimore	Androgen receptor down-regulating agents and uses thereof
KR20160058774A (ko)	2013-08-12	2016-05-25	토카이 파마슈티컬, 아이엔씨.	안드로겐-표적 치료제를 이용하는 종양 질환 치료를 위한 바이오마커
RS62421B1 (sr)	2014-12-05	2021-10-29	Aragon Pharmaceuticals Inc	Anti-kancerogeni sastavi
CN114886852A (zh) *	2014-12-05	2022-08-12	阿拉贡药品公司	抗癌组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3629237A (en) *	1968-09-12	1971-12-21	Shinetsu Chemical Co	Compositions useful as enteric coatings and method for preparing acid phthalates of cellulose ethers for them
US4309405A (en) *	1979-08-09	1982-01-05	American Home Products Corporation	Sustained release pharmaceutical compositions
DE3372965D1 (en) *	1982-07-23	1987-09-17	Ici Plc	Amide derivatives
US4946686A (en) *	1987-09-24	1990-08-07	Merck & Co., Inc.	Solubility modulated drug delivery system
ES2111065T5 (es) *	1991-04-16	2005-06-16	Nippon Shinyaku Company, Limited	Procedimiento para producir una dispersion solida.
CA2181358A1 (en) *	1994-01-21	1995-07-27	Nancy M. Gray	Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
CZ20032225A3 (cs) *	2001-02-27	2003-11-12	Astrazeneca Ab	Farmaceutická formulace
CZ20032647A3 (cs) *	2001-04-02	2004-09-15	Astrazeneca Ab	Pevná farmaceutická kompozice obsahující 4-kyanotrifluor-3-(4-fluorfenylsulfonyl)-2-hydroxy-2-methylpropiono-m-toluidin a PVP

2001
- 2001-10-15 SE SE0103424A patent/SE0103424D0/xx unknown
2002
- 2002-10-11 BR BR0213248-6A patent/BR0213248A/pt not_active Application Discontinuation
- 2002-10-11 KR KR1020047005493A patent/KR20050035163A/ko not_active Withdrawn
- 2002-10-11 WO PCT/GB2002/004621 patent/WO2003032950A1/en not_active Ceased
- 2002-10-11 MX MXPA04003520A patent/MXPA04003520A/es unknown
- 2002-10-11 IL IL16130602A patent/IL161306A0/xx unknown
- 2002-10-11 CA CA002462219A patent/CA2462219A1/en not_active Abandoned
- 2002-10-11 EP EP02770069A patent/EP1439823A1/en not_active Withdrawn
- 2002-10-11 PL PL02368226A patent/PL368226A1/xx not_active Application Discontinuation
- 2002-10-11 HU HU0401369A patent/HUP0401369A3/hu unknown
- 2002-10-11 US US10/492,629 patent/US20060058381A1/en not_active Abandoned
- 2002-10-11 CN CNA028203747A patent/CN1571658A/zh active Pending
- 2002-10-11 AR ARP020103826A patent/AR036877A1/es unknown
- 2002-10-11 JP JP2003535754A patent/JP3639587B2/ja not_active Expired - Fee Related
- 2002-10-11 RU RU2004115023/15A patent/RU2004115023A/ru not_active Application Discontinuation
2004
- 2004-04-07 ZA ZA200402729A patent/ZA200402729B/xx unknown
- 2004-04-13 NO NO20041485A patent/NO20041485L/no not_active Application Discontinuation
- 2004-04-14 IS IS7219A patent/IS7219A/is unknown
- 2004-05-12 CO CO04043957A patent/CO5580755A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20050035163A (ko)	2005-04-15
IS7219A (is)	2004-04-14
ZA200402729B (en)	2005-01-13
CO5580755A2 (es)	2005-11-30
MXPA04003520A (es)	2004-07-23
JP3639587B2 (ja)	2005-04-20
HUP0401369A2 (hu)	2004-11-29
JP2004521963A (ja)	2004-07-22
EP1439823A1 (en)	2004-07-28
US20060058381A1 (en)	2006-03-16
HUP0401369A3 (en)	2006-05-29
CA2462219A1 (en)	2003-04-24
CN1571658A (zh)	2005-01-26
SE0103424D0 (sv)	2001-10-15
BR0213248A (pt)	2004-09-28
PL368226A1 (en)	2005-03-21
AR036877A1 (es)	2004-10-13
IL161306A0 (en)	2004-09-27
RU2004115023A (ru)	2005-04-10
WO2003032950A1 (en)	2003-04-24

Legal Events

Date	Code	Title	Description
2006-05-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20033384L (no)	2003-09-25	Farmasoytisk formulering
NO20033785D0 (no)	2003-08-26	Farmasöytisk formulering
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
ITTO20010008A0 (it)	2001-01-10	Formulazione farmaceutica
FI20011478A0 (fi)	2001-07-05	Farmaseuttinen koostumus
NO20035627D0 (no)	2003-12-15	Farmasöytisk formulering
IS7051A (is)	2003-11-26	Lyfjasamsetningar
FI20022128L (fi)	2003-06-06	Farmaseuttinen koostumus
EP1408896A4 (en)	2010-02-24	PHARMACEUTICAL COMPOSITION
NO20042502L (no)	2004-08-09	Farmasoytisk formulering omfattende bicalutamid
IL161306A0 (en)	2004-09-27	Pharmaceutical formulation comprising (r)-bicalutamide
DE10291905D2 (de)	2004-05-27	Pharmazeutische Zusammensetzung
DK1429753T3 (da)	2007-05-14	Farmaceutisk sammensætning omfattende gamma-butyrobetain
NO20015534D0 (no)	2001-11-12	Farmasöytisk blandeapparat
EE200300465A (et)	2003-12-15	Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
DE10107261B4 (de)	2005-03-10	Pharmazeutische Zusammensetzung
NO20041236L (no)	2004-03-24	Farmasoytisk formulering
SE0101325D0 (sv)	2001-04-12	Pharmaceutical formulation
SE0102069D0 (sv)	2001-06-21	Pharmaceutical formulation
SE0101171D0 (sv)	2001-04-02	Pharmaceutical formulation
SE0101326D0 (sv)	2001-04-12	Pharmaceutical formulation
SE0102572D0 (sv)	2001-07-19	Pharmaceutical formulation
SE0102957D0 (sv)	2001-09-04	Pharmaceutical formulation
SE0103565D0 (sv)	2001-10-25	Pharmaceutical formulation
EP1413314A4 (en)	2004-12-22	MEDICAL COMPOSITIONS